GlassScriptPhysician profile
Shaoshan S Wang
NPI 1952354078
$5,267.52
in general payments reported to CMS, 2019-2025
35 companies · $695 in 2025
The $695 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $741 · 2021: $1,172 · 2022: $780 · 2023: $685 · 2024: $703 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,082.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $667.87 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $527.45 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $503.04 | 2019-2025 | Farxiga |
| Novartis Pharmaceuticals Corporation | $344.72 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $338.85 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $325.46 | 2019-2025 | |
| Novo Nordisk INC | $277.38 | 2021-2024 | Rybelsus, Ozempic |
| Biohaven Pharmaceuticals, INC. | $250.00 | 2020-2021 | |
| Biotronik INC. | $229.00 | 2022-2023 | Acticor 7 Vr-T Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $190.45 | 2020-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $180.90 | 2019-2021 | |
| Medtronic, INC. | $130.75 | 2025 | Micra |
| Inspire Medical Systems, INC. | $127.96 | 2024 | Inspire |
| Akcea Therapeutics, INC. | $125.82 | 2021 | |
| Kestra Medical Technology Services, INC. | $110.94 | 2024 | Assure Wcd |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $98.52 | 2020 | |
| Abbott Laboratories | $97.16 | 2022 | |
| Tempus Ai, INC | $92.94 | 2025 | Xt Cdx |
| Esperion Therapeutics, INC. | $91.89 | 2021 | |
| Merck Sharp & Dohme LLC | $73.47 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.06 | 2019-2024 | Jardiance |
| W. L. Gore & Associates, INC. | $58.86 | 2021 | |
| Boston Scientific Corporation | $50.13 | 2019 | |
| Beigene USA, INC. | $50.00 | 2022 | |
| Abiomed | $41.38 | 2024-2025 | Impella |
| Emd Serono, INC. | $41.25 | 2023 | Mavenclad |
| Teva Pharmaceuticals USA, INC. | $36.00 | 2020 | |
| Heartflow, INC. | $25.42 | 2025 | |
| Amarin Pharma, INC. | $21.89 | 2020 | |
| Lantheus Medical Imaging, INC. | $20.23 | 2021 | |
| Edwards Lifesciences Corporation | $19.87 | 2022 | |
| Bracco Diagnostics INC. | $17.13 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $13.75 | 2021 | |
| Terumo Medical Corporation | $12.95 | 2020 | |
| Janssen Scientific Affairs, LLC | $10.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaoshan Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.